Literature DB >> 20087731

The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry.

Michael S Bereman1, David C Muddiman.   

Abstract

We report the results of abundant plasma protein depletion on the analysis of underivatized N-linked glycans derived from plasma proteins by nanoLC Fourier-transform ion cyclotron resonance mass spectrometry. N-linked glycan profiles were compared between plasma samples where the six most abundant plasma proteins were depleted (n = 3) through a solid-phase immunoaffinity column and undepleted plasma samples (n = 3). Three exogenous glycan standards were spiked into all samples which allowed for normalization of the N-glycan abundances. The abundances of 20 glycans varying in type, structure, composition, and molecular weight (1,200-3,700 Da) were compared between the two sets of samples. Small fucosylated non-sialylated complex glycans were found to decrease in abundance in the depleted samples (greater than or equal to tenfold) relative to the undepleted samples. Protein depletion was found to marginally effect (less than threefold) the abundance of high mannose, hybrid, and large highly sialylated complex species. The significance of these findings in terms of future biomarker discovery experiments via global glycan profiling is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087731      PMCID: PMC2866188          DOI: 10.1007/s00216-009-3368-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  30 in total

1.  Alterations in the serum glycome due to metastatic prostate cancer.

Authors:  Zuzana Kyselova; Yehia Mechref; Mohammad M Al Bataineh; Lacey E Dobrolecki; Robert J Hickey; Jake Vinson; Christopher J Sweeney; Milos V Novotny
Journal:  J Proteome Res       Date:  2007-04-14       Impact factor: 4.466

2.  Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data.

Authors:  Donald A Barkauskas; Hyun Joo An; Scott R Kronewitter; Maria Lorna de Leoz; Helen K Chew; Ralph W de Vere White; Gary S Leiserowitz; Suzanne Miyamoto; Carlito B Lebrilla; David M Rocke
Journal:  Bioinformatics       Date:  2008-12-09       Impact factor: 6.937

3.  The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.

Authors:  Scott R Kronewitter; Hyun Joo An; Maria Lorna de Leoz; Carlito B Lebrilla; Suzanne Miyamoto; Gary S Leiserowitz
Journal:  Proteomics       Date:  2009-06       Impact factor: 3.984

4.  Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS.

Authors:  D Isailovic; R T Kurulugama; M D Plasencia; S T Stokes; Z Kyselova; R Goldman; Y Mechref; M V Novotny; D E Clemmer
Journal:  J Proteome Res       Date:  2008-02-01       Impact factor: 4.466

5.  Studying O-linked protein glycosylations in human plasma.

Authors:  Taufika Islam Williams; Diana A Saggese; David C Muddiman
Journal:  J Proteome Res       Date:  2008-04-19       Impact factor: 4.466

Review 6.  Functional roles of N-glycans in cell signaling and cell adhesion in cancer.

Authors:  Yan-Yang Zhao; Motoko Takahashi; Jian-Guo Gu; Eiji Miyoshi; Akio Matsumoto; Shinobu Kitazume; Naoyuki Taniguchi
Journal:  Cancer Sci       Date:  2008-05-19       Impact factor: 6.716

7.  Variability, heritability and environmental determinants of human plasma N-glycome.

Authors:  Ana Knezević; Ozren Polasek; Olga Gornik; Igor Rudan; Harry Campbell; Caroline Hayward; Alan Wright; Ivana Kolcic; Niaobh O'Donoghue; Jonathan Bones; Pauline M Rudd; Gordan Lauc
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  Development of a robust and high throughput method for profiling N-linked glycans derived from plasma glycoproteins by NanoLC-FTICR mass spectrometry.

Authors:  Michael S Bereman; Douglas D Young; Alexander Deiters; David C Muddiman
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

9.  Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients.

Authors:  Michael S Bereman; Taufika Islam Williams; David C Muddiman
Journal:  Anal Chem       Date:  2009-02-01       Impact factor: 6.986

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  5 in total

1.  Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure.

Authors:  Ioan Marginean; Scott R Kronewitter; Ronald J Moore; Gordon W Slysz; Matthew E Monroe; Gordon Anderson; Keqi Tang; Richard D Smith
Journal:  Anal Chem       Date:  2012-10-17       Impact factor: 6.986

2.  The use of a xylosylated plant glycoprotein as an internal standard accounting for N-linked glycan cleavage and sample preparation variability.

Authors:  S Hunter Walker; Amber D Taylor; David C Muddiman
Journal:  Rapid Commun Mass Spectrom       Date:  2013-06-30       Impact factor: 2.419

3.  Enrichment strategies in glycomics-based lung cancer biomarker development.

Authors:  L Renee Ruhaak; Uyen Thao Nguyen; Carol Stroble; Sandra L Taylor; Ayumu Taguchi; Samir M Hanash; Carlito B Lebrilla; Kyoungmi Kim; Suzanne Miyamoto
Journal:  Proteomics Clin Appl       Date:  2013-08-06       Impact factor: 3.494

4.  Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples.

Authors:  Elizabeth S Hecht; Elizabeth H Scholl; S Hunter Walker; Amber D Taylor; William A Cliby; Alison A Motsinger-Reif; David C Muddiman
Journal:  J Proteome Res       Date:  2015-09-14       Impact factor: 4.466

Review 5.  Developments in the identification of glycan biomarkers for the detection of cancer.

Authors:  L Renee Ruhaak; Suzanne Miyamoto; Carlito B Lebrilla
Journal:  Mol Cell Proteomics       Date:  2013-01-30       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.